FDA Acceptance of Surrogate End Points for Cancer Drug Approval

This retrospective review assesses the frequency of surrogate measures used for the first time vs subsequent times in a cancer setting and the surrogate ’s strength of correlation with patient-centered outcomes.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research